Azenta names Martin Madaus interim CEO as John Marotta resigns
Reuters2026/08/24 12:01- Azenta appointed director Dr. Martin Madaus as interim president and CEO in a leadership transition.
- John Marotta resigned as an executive officer and director.
- Madaus joined the board in 2024; he is a senior operating executive at Carlyle.
- He previously led Millipore, Ortho-Clinical Diagnostics, and Roche Diagnostics North America as CEO roles.
- Board retained Heidrick & Struggles to run a search for a permanent CEO.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Faraday Future adds government procurement veteran Steven Newton as senior strategic advisor
JPMorgan: Tesla (TSLA.US) Robotaxi revenue may reach $320 billions by 2035, with nearly 98% coming from its own fleet
JPMorgan analyst Rajat Gupta released a research report last week, estimating that by 2035, Tesla's Robotaxi revenue will reach approximately $320 billion, with nearly $314 billion coming from Tesla's own and operated fleet, rather than from the owner-operated "Tesla Network."
FDA approves Telix brain cancer imaging drug Pixclara for glioma PET scans
Charles Hoskinson Says AI Has Destroyed The Old Crypto Growth Metric
Crypto prices
More
